Site-Specific Chemical Modification of a Cytokine Mimic for Small Molecule-Based Tumor Targeting
Bioconjugate chemistry(2023)
摘要
The targeted delivery of bioactive proteins, such ascytokines,for cancer immunotherapy approaches mostly relies on antibodies orantibody fragments. However, fusion proteins may display low tissuepenetration due to a large molecular size. Small molecule ligandswith high affinity toward tumor-associated antigens provide a promisingalternative for the selective delivery of cytokines to tumor lesions.We developed a one-pot procedure for the site-specific thiazolidineformation between an aldehyde bearing small molecule and the in situ generated N-terminal cysteine of a bioactive protein.Thereby, neoleukin-2/15 (Neo-2/15), a computationally engineered interleukin-2and -15 mimic, was chemically conjugated to acetazolamide plus, apotent carbonic anhydrase IX (CAIX) ligand. The conjugate retainedthe biological activity of Neo-2/15 and revealed its ability to accumulatein renal cell carcinoma (SK-RC-52) xenografts upon systemic intravenousadministration. The results highlight the potential of small moleculetargeting moieties to drive the accumulation of a protein cargo tothe respective disease site while conserving the small construct size.
更多查看译文
关键词
tumor targeting,cytokine mimic,site-specific,molecule-based
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要